InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-47.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Ricciardi Lisa, Chairman & CEO. Insider active across 1 company, notably Cognition Therapeutics INC. Cumulatively, 10 disclosures have been published. Split: 5 buys · 0 sell. Total volume traded: €191k. Activity tracked since 13 October 2021. The latest transaction was disclosed on 16 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
9,175 shares@ US$1.100.0093% mcap2.2% of flowCommon StockSEC:0001104659-26-045502:0
Ideal exit: 11 Jan 2027 (T+270)
75,000 shares0Common StockSEC:0001062993-25-013356:0
6,619 shares@ US$0.59011.0% of flowCommon StockSEC:0001062993-25-002705:0
38,851 shares@ US$0.77227.7% of flowCommon StockSEC:0001062993-25-001617:0
Ideal exit: 28 Oct 2025 (T+270)
5,700 shares@ US$1.752.4% of flowCommon StockSEC:0001062993-24-006429:0
Ideal exit: 9 Dec 2024 (T+270)
75,000 shares0Common StockSEC:0001062993-24-003644:0
27,828 shares@ US$2.2915.7% of flowCommon StockSEC:0001062993-24-002774:0
213,973 shares0Common StockSEC:0000899243-23-004182:0
12,000 shares@ US$1.304.0% of flowCommon StockSEC:0001062993-22-022243:0
Ideal exit: 12 Aug 2023 (T+270)
12,500 shares@ US$12.000.11% mcap50.0% of flowCommon StockSEC:0001104659-21-126362:0
Ideal exit: 10 Jul 2022 (T+270)
10 of 10 declarations
About Ricciardi Lisa
Lisa Ricciardi is the Chief Executive Officer and President of COGNITION THERAPEUTICS INC. In this role, she oversees the operations and strategy of the company in the field of cognitive therapies. With significant experience in the biopharmaceutical sector, Lisa is responsible for growth and optimizing Cognition's performance. Her leadership is essential for achieving the company's objectives.
